Prognostic utility and characterization of left ventricular hypertrophy using global thickness

Area of Science:

• Cardiology
• Medical Imaging
• Biomedical Engineering

Background:

• Cardiovascular magnetic resonance (CMR) is crucial for measuring left ventricular (LV) mass.
• Existing LV wall thickness measures have limitations in prognostic assessment.
• Left ventricular hypertrophy (LVH) is a significant indicator of cardiovascular risk.

Purpose of the Study:

• To evaluate the prognostic value of different LV wall thickness measures derived from CMR.
• To introduce and validate a new measure, global wall thickness (GT).
• To determine the optimal measure for characterizing LV hypertrophy and predicting outcomes.

Main Methods:

• Retrospective analysis of 2543 cardiac patients and 100 healthy volunteers undergoing CMR.
• Calculation of LV mass, LV mass index (LVMI), and a novel global wall thickness (GT/GTI).
• Prognostic analysis using Cox regression for death or heart failure hospitalization, with a median follow-up of 5.4 years.

Main Results:

• LVMI was the strongest predictor of adverse outcomes in the overall patient cohort (HR 1.16).
• Global wall thickness indexed to body surface area (GTI) also showed significant prognostic value (HR 1.14).
• Among patients with normal LV mass, GT was the most predictive measure (HR 1.62), identifying early disease stages.

Conclusions:

• LVMI is highly prognostic for elevated LV mass.
• GT is a valuable, easily calculated measure that improves risk stratification, particularly in patients with normal LV mass.
• Combined use of GT and LVMI can effectively categorize patients into distinct prognostic groups based on LV morphology.